Press Releases Biomark Diagnostics Inc.

Equities

20B

CA09073K1084

Market Closed - Deutsche Boerse AG Other stock markets 11:04:37 2024-06-21 EDT			5-day change	1st Jan Change
0.142 ^EUR	+2.16%		+2.16%	-3.40%

02-29	Biomark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
02-28	BioMark Diagnostics Inc. Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Biomark Diagnostics : Announces Warrant Extension and Granting of Options	05-06	PU
BioMark Announces Warrant Extension and Granting of Options	04-18	NE
BioMark to Advance Development of Cancer Treatment for Glioblastoma	04-09	NE
BioMark Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities	02-28	NE
Theresa Peterson Joins Biomark's Advisory Team	02-26	NE
BioMark Announces Closing of $1.9 Million Non-Brokered Private Placement	12-29	NE
BioMark Announces Recent New Patent Granted in Canada to Support Its Liquid Biopsy Based Legacy Assay	12-04	NE
BioMark Provides Second Quarter Operational Update and Announces Extension to Warrant Exercise Term	11-28	NE
BioMark Strengthens and Expands Its Strategic Advisory Team in Pursuit of Commercialization Initiatives	11-14	NE
BioMark Announces Financial Contribution from the City of Quebec to Support Commercialization Initiatives of Its Proprietary Lung Cancer Detection Test	11-07	NE
BioMark to Unveil Results of Its Early Breast Cancer Study at the Upcoming San Antonio Breast Cancer Symposium	23-10-24	NE
Biomark Diagnostics : Une Technologie d’ici Pour Mieux Diagnostiquer le Cancer du Poumon – Local Technology for Improved Lung Cancer Diagnosis	23-09-10	PU
BioMark Diagnostics : Dr. Maksymuik Presents at Prestigous ASCO Annual Meeting	23-06-13	PU
BioMark Unveils Significant Scientific Advancements from Its Leading Liquid Biopsy Technology at ASCO 2023 Annual Meeting	23-06-05	NE
BioMark Announces Update from Ongoing Clinical Trial Using Its Lung Cancer Liquid Biopsy Test as It Prepares for Commercial Launch	23-01-11	NE
BioMark Diagnostics : Form 7 Monthly Progress Report December 1 2022	23-01-09	PU
BioMark Diagnostics : Form 7 Monthly Progress Report November 1 2022	22-12-12	PU
BioMark Continues to Strengthen its Intellectual Property position With New Patent	22-06-22	AQ
BioMark to Collaborate with Astrazeneca, Pfizer Canada and The IUCPQ Foundation in a $3.5m Project to Improve Early Detection of Lung Cancer	21-11-30	NE
BioMark Diagnostics : Material change report - English	21-11-25	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Biomark Diagnostics Inc.

Equities

20B

CA09073K1084

Press Releases

Filters